Middle ear mucosal inflammation: an in vivo model

Area of Science:

• Otolaryngology
• Inflammation research
• Medical imaging

Background:

• Otitis media (OM) pathogenesis involves inflammation, but research often uses in vitro methods.
• Magnetic resonance imaging (MRI) offers real-time in vivo insights into soft tissue, yet is underutilized in OM research.
• Histamine is a key inflammatory mediator in OM, with its treatment efficacy still debated.

Purpose of the Study:

• To assess experimental middle ear (ME) inflammation using MRI in a chinchilla model.
• To evaluate the vasoactive effects of histamine and its interaction with antihistamines and a glucocorticoid.
• To validate MRI as a tool for real-time assessment of mucosal inflammation.

Main Methods:

• Utilized sequential T1-weighted spin-echo (SE) MRI to detect gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA) extravasation into middle ear effusion (MEE).
• Administered histamine to chinchilla ME mucosa, assessing dose-related effects.
• Evaluated histamine challenge after pretreatment with hydroxyzine hydrochloride (H1 antagonist), ranitidine chloride (H2 antagonist), or dexamethasone (glucocorticoid).

Main Results:

• Histamine's vasoactive effects were dose-dependent and detectable at levels relevant to human MEE.
• H1 antagonist (alone or with H2 antagonist) prevented histamine-induced vascular permeability.
• H2 antagonist alone did not abolish histamine's effects, while dexamethasone ameliorated them.
• MRI successfully visualized real-time mucosal inflammation.

Conclusions:

• MRI is a valuable tool for real-time assessment of mucosal inflammation in experimental otitis media.
• H1 antihistamines and glucocorticoids effectively counteract histamine's vasoactive effects in the middle ear.
• This MRI methodology can be applied to evaluate other anti-inflammatory mediators in OM.